Loading
Genomtec S.A. Stock: price and insider trades · Poland
Genomtec S.A.: what insiders have been doing
Genomtec S.A., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to KNF. 2 insiders have disclosed 8 filings since 22 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (553 companies, median 3 filings), a count of 8 filings is above the norm.
Insider buying of Genomtec S.A. has been absent for the past year.
These figures are compiled from regulatory filings published by KNF. They describe what insiders did and are not a recommendation.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 2.93
Analyst consensus
Income statement
RevenuePLN 21k
Gross profit-PLN 8M-37910% margin
EBITDA-PLN 7.4M-35205% margin
Net income-PLN 10.4M-49671.4% margin
Valuation
P/Book3.2x
Beta0.33
Balance sheet & cash
Market capPLN 50M
Total debtPLN 1.9M
Free Cash Flow-PLN 11.3M
Debt / Equity11%
Profitability & ownership
ROE-55.5%
ROA-22.7%
% insiders15.4%
% institutions2.9%
Last declaration on 2 September 2026
Declarations8 total
●
Executives
0KNF
●
Executives
0KNF
●
Executives
20,240 PLN0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
●
Executives
0KNF
8 of 8 declarations
About Genomtec S.A.
Genomtec S.A. is a company focused on developing molecular diagnostic solutions. It aims to enhance health testing through innovative technologies.
